Erdman Macrolides & ketolides Flashcards

1
Q

chemical difference between erythromycin and clarithromycin

A

clarithromycin is a derivative of erythromycin that substitutes a methoxy group for the C-6 hydroxyl group

  • improves bioavailability (increases acid stability), enhances antibacterial activity, enhances tissue penetration and prolongs half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

chemical difference between erythromycin and azithromycin

A

azithromycin is a derivative of erythromycin that has an amino group inserted into the ring at position 9a. 15 membered ring - technically an “azalide”

  • improves bioavailabilty, antibacterial activity (especially against H. influenzae), tissue penetration and increased half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of macrolides

A

interfere with microbial protein synthesis (translocation step)

reversibly bind to 50s ribosomal subunit so that protein synthesis is supressed and growth is inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F: macrolides display bactericidal activity

A

False: they typically display bacteriostatic activity

at very susceptible organisms and at high concentrations they MAY have some bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the MOR for macrolides

A

Active efflux

Alteration in the binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do bacteria develop the active efflux machanism of resistance

A

mef gene encodes for pumps - confers LOW-LEVEL resistance to macrolides

macrolides may still be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do bacteria develop the alteration in binding site mechanism of resistance

A

erm gene causes a methylation of the macrolide 50S binding site leading to low affinity binding - confers HIGH-LEVEL resistance to ALL macrolides and other Abx that bind to 50S (clinda & synercid)

Sucks - common in Europe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F: cross resistance is NOT usually observed

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When bactericidal, macrolides display _______ activity

A

time-dependent

azithromycin may display concentration-dependent in “some cases”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gram (+) aerobe bacteria covered?

A

S. pneumoniae (65-70% of strains, primarily PSSP)

MSSA (mild-moderate only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which macrolide has the best gram (+) aerobe coverage

A

Clarithromycin

Clarithromycin > Erythromycin > Azithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which macrolide has the best gram (-) aerobe coverage

A

Azithromycin

Azithromycin > Clarithromycin > Erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gram (-) aerobes covered

A

NOT THE ENTEROBACTERIACEAE

H. influenzae (not erythromycin)
M. catarrhalis
Neisseria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atypical coverage?

A

Legionella pneumophila – a DOC*
Chlamydophila and Chlamydia spp.
Mycoplasma pneumoniae
Ureaplasma urealyticum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Absorption characteristics of erythromycin

A

variable bioavailability (15-45%)

  • base is acid labile and subject to destruction in stomach
  • ester and salt derivatives more stable in acid
  • food delays absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Absorption characteristics of clarithromycin

A

acid stable and well absorbed fro stomach regardless of food (F= 52-55%)
- peak concentration at about 3 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Absorption characteristics of azithromycin

A

acid stable, F= 37%

  • peak at 2-3 hours
  • food does not affect absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

distribution of macrolides

A
  • all distribute well into all tissues (EXCEPT CSF) and cells
  • obtain high tissue concentrations but minimal serum concentrations
    - may be ineffective against bacteremia*****
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which macrolide must be adjusted for renal insufficiency

A

Clarithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is erythromycin eliminated

A

biliary and hepatic (CYP450 enzymes)

21
Q

How is clarithromycin eliminated

A

extensively by hepatic (CYP450) and renal

dose adjust in CrCl <30

22
Q

How is azithromycin eliminated

A

biliary excretion

23
Q

Half lives of macrolides

A

Azithromycin (68 hrs) > Clarithromycin (3-7 hrs) > Erythromycin (1.4 hrs)

24
Q

T/F macrolides are removed during dialysis

A

False: NONE are removed

25
Used in the treatment of __________ in penicillin allergic patients
``` Group A strep Upper respiratory infections prophylaxis of bacterial endocarditis syphilis and gonorrhea superficial minor staph infections rheumatic fever prophylaxis ```
26
Used in the treatment of....
RTI uncomplicated skin and soft tissue infections STD mycobacterium avium complex infections (MAC)
27
What is the treatment of nongonococcal urethritis or cervicitis due to CHLAMYDIA TRACHOMATIS
a single 1-gram dose of azithromycin
28
T/F - clarithromycin and azithromycin have small volume of distributions
FALSE: very large Vds
29
Other bacterial coverage by macrolides?
Mycobacterium avium complex (MAC – only A and C)
30
macrolide treatment of CAP?
monotherapy in outpatients and in combination with ceftriaxone for inpatients *especially for atypical coverage*
31
macrolide tx of MAC
azithromycin for prophylaxis | clarithromycin for treatment
32
ADE with macrolide use
gastronintestinal, thrombophlebitis/infusion site irritation, QT prolongation
33
when is gastrointestinal SE most common and how can it be minimized
oral administration of erythromycin - give with food if possible
34
How to partially avoid thrombophlebitis
dilute the dose (at least 250mL), infuse slowly, and give into a large vein
35
Ototoxicity is seen...?
rarely - in patients with renal insufficiency and receiving high doses of erythromycin IV
36
Drug interactions of E & C
both inhibitors of CYP450 theophylline, carbamazepine, valproate, cyclosporin, digoxin, phenytoin, warfarin may increase serum concentrations & risk of toxicity
37
Drug interactions for azithromycin
not an inhibitor of CYP450 - no drug-drug interactions however monitor PT/INR on patients stable on warfarin due to cases of hypoprothrombinemia
38
Only approved ketolide is
telithromycin
39
difference in MOA between macrolides and ketolide
ketolide binds to 2 different sites (domain II and V) on the ribosome 10 times tighter binding to domain II -> provides activity against macrolide resistant strains
40
MOR of ketolide
alteration in binding site
41
ketolides display ______ activity
bacteriostatic **concentration-dependent cidal activity against some organisms*
42
Spectrum of activity of ketolide
same as macrolides (A&C) except - covers macrolide-resistant S. pnuemoniae - potentially less active against M. catarrhallis & H. influenzae - 10x better against borrelia burgdorferi
43
T/F: telithromycin is available only IV
false: only oral
44
Pharmacollogy of ketolide
A - F=57%, Tmax in 1-2 hours and NOT affected by food D - penetrates tissues well E - metabolized by CYP450 and feces - No dosage adjustment for renal insufficiency
45
ADE for telithromycin
hepatotoxicity & diarrhea, QTc prolongation (exacerbation of myasthenia), decreased visual acuity and blurred vision
46
Drug interactions of ketolides
CYP450 drugs (similar to C & E macrolides)
47
Only FDA approved use of ketolide
CAP
48
Telithromycin dose for tx of CAP
800 mg QD x7-10 days
49
T/F: telithromycin is approved for the tx of sinusitis and brochitis
FALSE - no longer approved due to adverse effect profile